Associated Genetic Biomarkers
NCI Definition: A lymphoma that arises within the eye. Signs and symptoms include decreased vision, uveitis, and vitreous floaters. 
There are 2 clinical trials for intraocular lymphoma, of which 2 are open and 0 are completed or closed. Of the trials that contain intraocular lymphoma as an inclusion criterion, 1 is phase 1 (1 open) and 1 is phase 1/phase 2 (1 open).
MYC is the most frequent gene inclusion criterion for intraocular lymphoma clinical trials .
Autologous hematopoietic stem cell transplantation, carmustine, and cyclophosphamide are the most common interventions in intraocular lymphoma clinical trials.
Significant Genes in Intraocular Lymphoma
MYC is an inclusion eligibility criterion in 1 clinical trial for intraocular lymphoma, of which 1 is open and 0 are closed. Of the trial that contains MYC status and intraocular lymphoma as inclusion criteria, 1 is phase 1/phase 2 (1 open) .
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.